Trans sodium crocetinate/cyclodextrin to increase diffusion of oxygen
Diffusion Pharmaceuticals Inc., a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to
A forum for researchers, students and applicants in the field of cyclodextrin technology
Diffusion Pharmaceuticals Inc., a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to
Crocetin (CRT) has shown various neuroprotective effects such as antioxidant activities and the inhibition of amyloid β fibril formation, and
The Table below was published in e-book International Pulmonologist’s Consensus On Covid-19 2nd ed 2020 on April 22nd 2020 (ed. Tinku
The New York Times published on June 22, 2020: The American biopharmaceutical company Gilead Sciences will soon start trials of
Researchers led by Professor Peter Horby at the University of Oxford, in England say they have the first evidence that
In a pandemic like Covid-19 the urgent need excludes the development of new drugs, “conventional drug in new use” becomes
Vaccines against COVID-19 will hopefully give broad parts of the human population a safe level of immunity and are considered
The gender gap in coronavirus survival became apparent early in the pandemic. Reports from China indicated men were dying at
As the readers of Cyclodextrin News have been already informed, 2020 BIO International Convention will be a digital event to
Amirian and Levy have recently collected the knowledge on remdesivir and its nucleoside analog [1]. This overview can be interesting